Doctors are grappling with a raft of unsparing hospital-acquired superbugs broadly known as anti-microbial resistance or AMR. Are bacterial infections the next big lethal adversary for mankind?
Related Posts
Cipla Stock: Cipla is banking on US growth and strong India business. But are the positives priced in its stock?
Cipla has become one of the favourite large-cap stocks of investors of late. Since the Covid-19 outbreak in March 2020,…
obesity: Tale of two anti-obesity drugs for diabetics: Does the euphoria signal an end to the chronic disease?
For most diabetics, an age-old challenge has been the inability to lose weight despite workouts. For millions of others, tweaking…
This Ranjan Pai investment opens the door to a USD30 billion opportunity
Ranjan Pai is among India’s most influential investors. So, when he makes a move into senior care, it is time…
